When people are in the early stages of an undiagnosed disease, immediate tests that lead to treatment are the best first steps. A technique using microneedles able to draw relatively large amounts of interstitial fluid – a liquid that lurks just under the skin – opens new possibilities. The new method’s larger draws could be more effective in rapidly measuring exposure to chemical and biological warfare agents, as well as diagnosing cancer and other diseases.
The City of Los Angeles, under the oversight of Mayor Eric Garcetti and built on the ShakeAlert system developed by the U.S. Geological Survey, has released ShakeAlertLA, a mobile application that sends alerts to users within Los Angeles County that an earthquake of greater than magnitude 5.0 or Level IV intensity has been detected and that they may soon feel shaking.
ERADA Technology Alliance have announced the imminent launch of a world first diagnostic saliva test for malaria. The saliva-based diagnostic tool, to be marketed by ERADA as a Saliva-based Malaria Asymptomatic and Asexual Rapid Test (SMAART) for subclinical infection, is set to transform malaria detection worldwide in the fight against one of the globe’s most deadly diseases.
The Strategic National Stockpile (SNS) Preparedness Course is a five-day course designed to give federal, state, and local officials information on how to best plan and prepare for a public health emergency and how to use and manage the Strategic National Stockpile in response to a terrorist attack, natural disaster, or technological accident.
The Blue Ribbon Study Panel on Biodefense welcomed former White House Homeland Security Advisor, Lisa Monaco, as a panel member. Monaco served as Assistant to the President for Homeland Security and Counterterrorism between 2013 and 2017. She replaces outgoing panel member, former Secretary of Health and Human Services Donna Shalala, who was recently elected to serve as a U.S. Representative for the 27th District in Florida.
On Friday, December 28, the Department of Health and Human Services (HHS) released the “Health Industry Cybersecurity Practices (HICP): Managing Threats and Protecting Patients” publication. The four-volume publication aims to provide voluntary cybersecurity practices to healthcare organizations of all types and sizes, ranging from local clinics to large hospital systems.
As 2018 ends, Puerto Rico’s transformation from hurricanes Irma and Maria has pivoted toward making the island stronger and more resilient. The island’s long-term recovery envisions enhanced infrastructure and communities more capable of withstanding events like the 2017 hurricanes. The government of Puerto Rico and Federal Emergency Management Agency (FEMA) have collaborated on several recovery projects that meet these objectives.
Secretary of Homeland Security Kirstjen M. Nielsen released the following statement after the U.S. Senate passed the Countering Weapons of Mass Destruction Act of 2018 (H.R. 7213). This legislation permanently establishes the Countering Weapons of Mass Destruction (CWMD) Office within the Department of Homeland Security (DHS), granting it needed authorities to protect the American people against evolving WMD threats.
Each year, the U.S. Department of Agriculture Forest Service uses prescribed fire and mechanical treatments to limit the potential for extreme fire activity on national forests. National forest fire and fuels programs were designed to reduce and remove excess vegetation. Years of research confirms that these treatments result in better fire suppression outcomes and help firefighters in their response efforts.
As part of the nation’s overall pandemic preparedness strategy, HHS set a preparedness goal of establishing and maintaining a stockpile of bulk vaccine antigen and adjuvants for influenza viruses with pandemic potential to vaccinate 26 million people immediately after a pandemic is declared. The results of the “BARDA Ready In Times of Emergency” (BRITE) study has determined that the H5N1 influenza vaccine stored for more than a decade in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS) is still safe and immunogenic.